Welcome to another insightful episode (#71) of the Patent Effect Podcast, where we dive into a critical topic for Türkiye’s and the global pharmaceutical and IP landscape: Bolar Exemption in Türkiye – Balancing Innovation and Access.
This week, Mustafa Cakir sits down with Ecem Gökçe Yağmur and Mert Parlar from SIMAJ (Our sponsor for this episode) to unpack one of the most important, and sometimes misunderstood, legal mechanisms in pharma patents: the Bolar Exemption.
In this episode, we cover:
What the Bolar Exemption is and how it works
How it entered EU and Turkish law
What activities are allowed (and not allowed) under this exemption
Its impact on innovators, generic companies, and public health
Whether you’re a patent attorney, in-house counsel, researcher, or policy-maker, this episode will give you valuable insights into one of the most debated aspects of pharma patent law.
Tune in now, subscribe for future episodes, and share this episode with your colleagues.
----------------------------------
Don’t forget to follow Patent Effect on LinkedIn and Twitter :)
You can also subscribe free to our weekly newsletter “Patent Raporu”, published with the motto “Weekly patent information service.” Follow our content via patentraporu.com, WhatsApp, or Telegram—whichever you prefer. — — — — — — — — — — —
For detailed information about Patentiv, the platform we developed for AI-powered patent valuation and commercialization, please visit our page. www.patentiv.com
— — — — — — — — — — —
Powered by www.patenteffect.com
— — — — — — — — — — —
Music: Beauty Flow Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License
http://creativecommons.org/licenses/by/3.0/
